Item 8.01 Other Events
1
--------------------------------------------------------------------------------
On January 10, 2023, Acutus Medical, Inc. ("the Company") received a letter from
The Nasdaq Stock Market LLC notifying the Company that it had regained
compliance with Listing Rule 5450(a)(1), which requires that listed securities
maintain a minimum closing bid price of at least $1.00 per share (the "Minimum
Bid Requirement"). The Company regained compliance with the Minimum Bid
Requirement based on the closing bid price of the Company's common stock on the
Nasdaq Global Select Market between December 23, 2022 and January 9, 2023. The
Company had previously been notified of its non-compliance with the Minimum Bid
Requirement on November 2, 2022, as described in the Company's Current Report on
Form 8-K filed on November 4, 2022.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Exhibit
Number Description
104.0 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses